Medicinova, Inc. (MNOV)

Price$1.47

Favorite Metrics

Price vs S&P 500 (26W)11.66%

Price vs S&P 500 (4W)-6.76%

Market Capitalization$71.37M

All Metrics

Book Value / Share (Quarterly)$0.84

P/TBV (Annual)1.75x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.20

Price vs S&P 500 (YTD)8.28%

Gross Margin (TTM)7.58%

Net Profit Margin (TTM)-2229.61%

EPS (TTM)$-0.19

10-Day Avg Trading Volume0.03M

EPS Excl Extra (TTM)$-0.19

EPS (Annual)$-0.24

ROI (Annual)-28.85%

Gross Margin (Annual)7.58%

Net Profit Margin (5Y Avg)-1094.76%

Cash / Share (Quarterly)$0.63

ROA (Last FY)-26.31%

EBITD / Share (TTM)$-0.21

ROE (5Y Avg)-19.16%

Operating Margin (TTM)-2460.70%

Cash Flow / Share (Annual)$-0.20

P/B Ratio1.72x

P/B Ratio (Quarterly)1.55x

Net Income / Employee (Annual)$-2

EV / Revenue (TTM)99.02x

Net Interest Coverage (TTM)-10.07x

ROA (TTM)-19.16%

EPS Incl Extra (Annual)$-0.24

Current Ratio (Annual)8.16x

Quick Ratio (Quarterly)8.11x

3-Month Avg Trading Volume0.07M

52-Week Price Return1.38%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$0.75

P/S Ratio (Annual)174.22x

Asset Turnover (Annual)0.01x

52-Week High$1.96

Operating Margin (5Y Avg)-1184.24%

EPS Excl Extra (Annual)$-0.24

CapEx CAGR (5Y)-40.83%

Tangible BV CAGR (5Y)-11.17%

26-Week Price Return18.55%

Quick Ratio (Annual)8.11x

13-Week Price Return-6.96%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)8.16x

Enterprise Value$40.564

Asset Turnover (TTM)0.01x

Book Value / Share Growth (5Y)-11.82%

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-2927.30%

Cash / Share (Annual)$0.63

3-Month Return Std Dev67.22%

Gross Margin (5Y Avg)36.04%

Net Income / Employee (TTM)$-2

ROE (Last FY)-28.85%

Net Interest Coverage (Annual)342.00x

EPS Basic Excl Extra (Annual)$-0.24

Receivables Turnover (TTM)0.00x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.19

ROI (TTM)-20.69%

P/S Ratio (TTM)174.22x

Pretax Margin (5Y Avg)-1094.13%

Revenue / Share (Annual)$0.01

Tangible BV / Share (Annual)$0.75

Price vs S&P 500 (52W)-33.25%

Year-to-Date Return12.21%

5-Day Price Return4.26%

EPS Normalized (Annual)$-0.24

ROA (5Y Avg)-17.91%

Net Profit Margin (Annual)-2928.76%

Month-to-Date Return7.30%

Cash Flow / Share (TTM)$-0.19

EBITD / Share (Annual)$-0.27

Operating Margin (Annual)-3242.44%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-19.16%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.19

P/TBV (Quarterly)1.75x

P/B Ratio (Annual)1.55x

Pretax Margin (TTM)-2228.15%

Book Value / Share (Annual)$0.84

Price vs S&P 500 (13W)-9.34%

Beta0.69x

P/FCF (Annual)87.04x

Revenue / Share (TTM)$0.01

ROE (TTM)-20.69%

52-Week Low$1.17

Analyst Recommendations

Jan 2026

Feb 2026

Mar 2026

Apr 2026

4.13

4.14

4.13

4.10

Industry Peers — Pharmaceuticals(308)

Symbol	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
MNOVMedicinova, Inc.	174.22x	—	7.58%	—	$1.47
LLYEli Lilly & Co.	13.45x	44.70%	83.04%	27.59%	$919.90
JNJJohnson & Johnson	5.82x	7.87%	67.95%	14.90%	$230.69
ABBVABBVIE INC.	5.97x	8.57%	71.62%	-2.88%	$203.71
MRKMerck & Co., Inc.	4.51x	1.31%	78.55%	21.23%	$117.10
AZNAstraZeneca PLC	5.39x	8.63%	81.31%	21.88%	$200.69
NVSNovartis AG	4.87x	8.91%	75.82%	15.26%	$150.99
NVONovo-Nordisk A/S	3.74x	6.43%	80.98%	20.66%	$40.46
ABTAbbott Laboratories	3.71x	6.59%	56.50%	8.20%	$96.00
PFEPfizer Inc.	2.50x	-1.64%	75.81%	-3.51%	$27.52
BMYBristol-Myers Squibb Co.	2.52x	-0.22%	72.63%	—	$59.13

About

MediciNova is a biopharmaceutical company that develops small-molecule therapeutics for diseases with unmet medical needs, with particular focus on neurological disorders and fibrotic diseases in the U.S. market. The company's pipeline includes candidates such as MN-001, MN-166, and MN-221, developed through a strategy of acquiring and advancing promising therapeutic assets.